Alkermes plc. (ALKS) Insider Trading -- Recent Executive & Director Transactions

15 insiders reported 205 Form 4 transactions for Alkermes plc. (ALKS) over the past 18 months (most recent 2026-07-06). Recent activity: Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) Sell 2,034 shares, Hopkinson Craig C. (EVP R&D, Chief Medical Officer) Buy 5,000 shares, Hopkinson Craig C. (EVP R&D, Chief Medical Officer) Sell 8,300 shares, Hopkinson Craig C. (EVP R&D, Chief Medical Officer) Sell 700 shares, Wright Christopher I (Director) Sell 2,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-06Gaffin David JosephEVP, CLO, Alkermes, Inc.Sell2,034$109,897
2026-07-01Hopkinson Craig C.EVP R&D, Chief Medical OfficerBuy5,000$96,700
2026-07-01Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell8,300$427,129
2026-07-01Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell700$36,492
2026-06-12Wright Christopher IDirectorSell2,000$90,200
2026-06-01Hopkinson Craig C.EVP R&D, Chief Medical OfficerBuy5,000$96,700
2026-06-01Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell9,000$375,044
2026-05-29Parisi Samuel JosephVP, Finance (Interim PAO)Buy3,392$67,942
2026-05-29Parisi Samuel JosephVP, Finance (Interim PAO)Buy12,825$248,036
2026-05-29Parisi Samuel JosephVP, Finance (Interim PAO)Sell16,217$687,007
2026-05-22Lurker NancyDirectorBuy6,142$0
2026-05-22LAURENCIN CATO TDirectorBuy6,142$0
2026-05-22MCKEON BRIAN PDirectorBuy6,142$0
2026-05-22Wilson Frank AndersDirectorBuy6,142$0
2026-05-22Cooke ShaneDirectorBuy6,142$0
2026-05-22snyderman nancy lynn MDDirectorBuy6,142$0
2026-05-22GAYNOR RICHARDDirectorBuy6,142$0
2026-05-22Wright Christopher IDirectorBuy6,142$0
2026-05-22MCKEON BRIAN PDirectorSell1,475$54,501
2026-05-22LAURENCIN CATO TDirectorSell1,475$54,501
2026-05-22Lurker NancyDirectorSell1,475$54,501
2026-05-22Wilson Frank AndersDirectorSell1,475$54,501
2026-05-22Cooke ShaneDirectorSell3,207$118,499
2026-05-22snyderman nancy lynn MDDirectorSell1,475$54,501
2026-05-22GAYNOR RICHARDDirectorSell1,475$54,501

Source: SEC Form 4 filings · as of 2026-07-06